These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35088024)

  • 1. Temporary Rise in Blood Thrombogenicity in Patients with Acute Myocardial Infarction.
    Kosugi S; Ueda Y; Abe H; Ikeoka K; Mishima T; Ozaki T; Takayasu K; Ohashi T; Yamane H; Nakamura M; Fukushima T; Horiuchi K; Iehara T; Osaki S; Ozato K; Inoue K; Koretsune Y; Matsumura Y
    TH Open; 2022 Jan; 6(1):e26-e32. PubMed ID: 35088024
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Kikuchi S; Tsukahara K; Ichikawa S; Abe T; Minamimoto Y; Kimura Y; Akiyama E; Nakayama N; Okada K; Matsuzawa Y; Konishi M; Maejima N; Iwahashi N; Hibi K; Kosuge M; Ebina T; Tamura K; Kimura K
    Circ J; 2020 May; 84(6):975-984. PubMed ID: 32188836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the Total Thrombus-Formation Analysis System as a Tool for Evaluating Thrombogenicity and Monitoring Antithrombotic Therapy in Pediatric Fontan Patients.
    Matsuo O; Ishii M; Kaikita K; Morinaga J; Miyamura F; Matsumoto S; Tsujita K; Nakamura K
    Pediatr Cardiol; 2023 Jun; 44(5):1150-1159. PubMed ID: 36550317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient increase in blood thrombogenicity may be a critical mechanism for the occurrence of acute myocardial infarction.
    Ueda Y; Kosugi S; Abe H; Ozaki T; Mishima T; Date M; Uematsu M; Koretsune Y
    J Cardiol; 2021 Mar; 77(3):224-230. PubMed ID: 32921530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease.
    Kaikita K; Hosokawa K; Dahlen JR; Tsujita K
    Thromb Haemost; 2019 Oct; 119(10):1554-1562. PubMed ID: 31330558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Infarction Associates With a Distinct Pericoronary Adipose Tissue Radiomic Phenotype: A Prospective Case-Control Study.
    Lin A; Kolossváry M; Yuvaraj J; Cadet S; McElhinney PA; Jiang C; Nerlekar N; Nicholls SJ; Slomka PJ; Maurovich-Horvat P; Wong DTL; Dey D
    JACC Cardiovasc Imaging; 2020 Nov; 13(11):2371-2383. PubMed ID: 32861654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals.
    Yamaguchi Y; Moriki T; Igari A; Matsubara Y; Ohnishi T; Hosokawa K; Murata M
    Thromb Res; 2013 Aug; 132(2):263-70. PubMed ID: 23777751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The level of blood thrombogenicity was not elevated in stable patients with disrupted coronary plaque.
    Ueda Y; Matsuo K; Nishio M; Hirata A; Asai M; Nemoto T; Murakami A; Kashiwase K; Kodama K
    J Cardiol; 2013 May; 61(5):326-9. PubMed ID: 23465867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early repolarization pattern associated with coronary artery disease and increased the risk of cardiac death in acute myocardium infarction.
    Fan J; Yao FJ; Cheng YJ; Ji CC; Chen XM; Wu SH
    Ann Noninvasive Electrocardiol; 2020 Nov; 25(6):e12768. PubMed ID: 32364308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis on the short-term outcome of patients with acute myocardial infarction complicating cardiogenic shock due to left main disease].
    Guo C; Xu HB; Duan X; Hu XY; Zhang J; Li J; Gao XJ; Luo XL; Yang WX; Hu FH; Wu Y; Qiao SB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):278-283. PubMed ID: 31060186
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a plasma metabolomic signature of thrombotic myocardial infarction that is distinct from non-thrombotic myocardial infarction and stable coronary artery disease.
    DeFilippis AP; Trainor PJ; Hill BG; Amraotkar AR; Rai SN; Hirsch GA; Rouchka EC; Bhatnagar A
    PLoS One; 2017; 12(4):e0175591. PubMed ID: 28414761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis-related low thrombogenicity measured by total thrombus-formation analysis system in patients undergoing percutaneous coronary intervention.
    Nakanishi N; Kaikita K; Ishii M; Kuyama N; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Kanazawa H; Hanatani S; Sueta D; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejimaa H; Matsushita K; Tsujita K
    Thromb Res; 2021 Apr; 200():141-148. PubMed ID: 33610886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial.
    Gibson CM; Zorkun C; Molhoek P; Zmudka K; Greenberg M; Mueller H; Wesdorp J; Louwerenburg H; Niederman A; Westenburg J; Bikkina M; Batty J; de Winter J; Murphy SA; McCabe CH
    J Thromb Thrombolysis; 2006 Aug; 22(1):13-21. PubMed ID: 16786228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level.
    Chuang AM; Nguyen MT; Khan E; Jones D; Horsfall M; Lehman S; Smilowitz NR; Lambrakis K; Than M; Vaile J; Sinhal A; French JK; Chew DP
    PLoS One; 2021; 16(3):e0248289. PubMed ID: 33711079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of Galectin-3 for the occurrence of coronary artery disease and prognosis after myocardial infarction and its association with carotid IMT values in these patients: A mid-term prospective cohort study.
    Lisowska A; Knapp M; Tycińska A; Motybel E; Kamiński K; Święcki P; Musiał WJ; Dymicka-Piekarska V
    Atherosclerosis; 2016 Mar; 246():309-17. PubMed ID: 26828748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombogenic potential of whole blood is higher in patients with acute coronary syndrome than in patients with stable coronary diseases.
    Matsuo K; Ueda Y; Nishio M; Hirata A; Asai M; Nemoto T; Kashiwase K; Kodama K
    Thromb Res; 2011 Sep; 128(3):268-73. PubMed ID: 21531446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction.
    Gibson CM; Ryan KA; Murphy SA; Mesley R; Marble SJ; Giugliano RP; Cannon CP; Antman EM; Braunwald E
    J Am Coll Cardiol; 1999 Oct; 34(4):974-82. PubMed ID: 10520778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombogenicity and central pulse pressure to enhance prediction of ischemic event occurrence in patients with established coronary artery disease: The MAGMA-ischemia score.
    Bliden KP; Chaudhary R; Navarese EP; Sharma T; Kaza H; Tantry US; Gurbel PA
    Atherosclerosis; 2018 Jan; 268():55-62. PubMed ID: 29175655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased thrombolysis in myocardial infarction frame count in patients with myocardial infarction and normal coronary arteriogram: a possible link between slow coronary flow and myocardial infarction.
    Yetkin E; Turhan H; Erbay AR; Aksoy Y; Senen K
    Atherosclerosis; 2005 Jul; 181(1):193-9. PubMed ID: 15939072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased thrombogenicity is associated with revascularization outcomes in patients with chronic limb-threatening ischemia.
    Kuyama N; Kaikita K; Ishii M; Mitsuse T; Nakanishi N; Fujisue K; Otsuka Y; Hanatani S; Sueta D; Takashio S; Araki S; Yamamoto E; Matsushita K; Tsujita K
    J Vasc Surg; 2022 Aug; 76(2):513-522.e3. PubMed ID: 35390483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.